MERIN MATHEW: Open Payments
NPI 1861844276 · FRISCO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,561 in 127 payments from 27 companies in 2025. Trend: 2023 $2,253 · 2024 $2,066 · 2025 $2,561
Food & beverage: $2,528Education: $32
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $392 |
| Amgen Inc. | 17 | $282 |
| Xeris Pharmaceuticals, Inc. | 11 | $230 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 14 | $203 |
| Mannkind Corporation | 14 | $188 |
| Antares Pharma, Inc. | 6 | $134 |
| Corcept Therapeutics | 5 | $126 |
| Tandem Diabetes Care, Inc. | 7 | $115 |
| IBSA Pharma Inc. | 6 | $114 |
| Radius Health, Inc. | 5 | $113 |
Products named: Ozempic, JARDIANCE, EVENITY, AFREZZA, XYOSTED, GVOKE HYPOPEN, Korlym, t:slim X2 Insulin Pump with Control-IQ.
Industry payments across TX — which companies pay providers there.
